EUVIMEDEUVIMED entdecken
Crossref

Robinetin Modulates TGF-β/ERK Signaling and Tumor-Associated Phenotype in 3D Osteosarcoma Spheroids

Isabela Santos, Seokgyu Han, Omar Gabriel Hernández Zapata iD, Brittany Alejandra Garibay Corral, Jihyun Lee, Francisco Conceição iD, José Miguel P Ferreira de Oliveira, Eduarda Fernandes iD, Su Ryon Shin iD

ACS Biomaterials Science & Engineering · 10.08.2026 · 12 (8) · 4478-4492

DOI: 10.1021/acsbiomaterials.6c00437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 21.07.2026. Verfasst von Isabela Santos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, Massachusetts02139, Uni…. Hauptthemen laut MEDLINE: Osteosarcoma, Spheroids, Cellular, Bone Neoplasms, Antineoplastic Agents. Die Arbeit nennt 66 Literaturangaben. Gefördert von: NIAMS NIH HHS, Fulbright Association, Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OS) is the most frequent primary bone malignancy, with stagnant therapeutic progress. The current chemotherapy treatment shows limited efficacy in disseminating metastasis, and its recurrent use is associated with high systemic toxicity. Moreover, the absence of effective therapeutic strategies along with low complexity models for drug screen analysis hinders therapeutic progress. Herein, by developing a three-dimensional (3D) OS model, we found that compared to two-dimensional (2D) OS culture, the 3D spheroid model exhibited upregulation of pro-tumorigenic genes (IL6, OPN, and MMP2), as well as 3D-exclusive activation of TGF-β1 and p-ERK1/2. Additionally, we report the anticancer potential of robinetin, which successfully suppressed pro-tumorigenic genes and downregulated TGF-β1 and p-ERK1/2, demonstrating antitumor efficacy at a similar magnitude as doxorubicin while exhibiting low toxicity toward a healthy mesenchymal 3D system. In a scaffold-based 3D model with bone-mimicking stiffness, robinetin treatment suppressed pro-tumorigenic genes related to tumor invasiveness (FN1, OPN, IL6, and MMP2) and decreased the viability of OS cells upon exposure to TGF-β1. This study highlights robinetin as a promising candidate for selective OS therapy while emphasizing the reliability of advanced 3D OS models for anticancer drug screening and translational research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaSpheroids, CellularBone NeoplasmsAntineoplastic AgentsMAP Kinase Signaling SystemTransforming Growth Factor betaTransforming Growth Factor beta1HumansCell Line, TumorPhenotypeSignal Transduction

Stichwörter der Autor:innen

3D tumor spheroidflavonoidsinvasionosteosarcomatransforming growth factor beta

Substanzen

Antineoplastic AgentsTransforming Growth Factor betaTransforming Growth Factor beta1

Autor:innen und Institutionen

  • Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, Massachusetts02139, United States.
  • LAQV, REQUIMTE, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, Porto4050-313, Portugal.
  • School of Engineering and Science, Tecnológico de Monterrey, Tlalpan, Mexico City14380, México.
  • School of Engineering and Science, Tecnológico de Monterrey, Chihuahua, Chihuahua31150, México.
  • Department of Bioengineering Technologies, Faculty of Science and Technology, TechMedCentre, University of Twente, NB, Enschede7522, the Netherlands.

ORCID-Profile: Omar Gabriel Hernández Zapata, Francisco Conceição, Eduarda Fernandes, Su Ryon Shin

Förderung

  • NIAMS NIH HHS
  • Fulbright Association
  • Fundação para a Ciência e a Tecnologia
  • Fundação Luso-Americana para o Desenvolvimento
  • Laboratório Associado para a Química Verde
  • National NanoFab Center
  • Funda??o Luso-Americana para o Desenvolvimento
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Santos, I., Han, S., Hernández Zapata, O. G., Corral, B. A. G., Lee, J., Conceição, F., Oliveira, J. M. P. F., Fernandes, E., & Shin, S. R. (2026). Robinetin Modulates TGF-β/ERK Signaling and Tumor-Associated Phenotype in 3D Osteosarcoma Spheroids. ACS Biomaterials Science & Engineering, 12(8), 4478-4492. https://doi.org/10.1021/acsbiomaterials.6c00437

Vancouver

Santos I, Han S, Hernández Zapata OG, Corral BAG, Lee J, Conceição F, et al. Robinetin Modulates TGF-β/ERK Signaling and Tumor-Associated Phenotype in 3D Osteosarcoma Spheroids. ACS Biomaterials Science & Engineering. 2026;12(8):4478-4492. doi:10.1021/acsbiomaterials.6c00437

BibTeX
@article{Santos2026,
  author = {Santos, Isabela and Han, Seokgyu and Hernández Zapata, Omar Gabriel and Corral, Brittany Alejandra Garibay and Lee, Jihyun and Conceição, Francisco and Oliveira, José Miguel P Ferreira de and Fernandes, Eduarda and Shin, Su Ryon},
  title = {Robinetin Modulates TGF-β/ERK Signaling and Tumor-Associated Phenotype in 3D Osteosarcoma Spheroids},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2026},
  volume = {12},
  number = {8},
  pages = {4478--4492},
  doi = {10.1021/acsbiomaterials.6c00437}
}
Kostenlos starten →